INCOG BioPharma Services, a biopharmaceutical manufacturing services startup specializing in injectable drug products, announced plans to establish its first manufacturing facility and global headquarters in Fishers.
The company plans to create up to 150 new, high-wage jobs by the end of 2024. It is investing approximately $60 million to construct and equip a 60,000-sq.ft. facility in Fishers.
The new building will enable INCOG BioPharma to launch its manufacturing operations, which will support biopharmaceutical companies in advancing and accelerating early phase clinical projects to commercial launch and routine commercial re-supply.
With its investment, the company plans to purchase and install state-of-the-art equipment to operate in a controlled, clean-room environment. Groundbreaking is expected as early as December 2020 and the facility will be fully operational in the first half of 2022.
INCOG BioPharma plans to add more than 65 team members over the next two years and continue ramping up hiring as customer demand increases. Hiring will begin in early 2021 for positions in engineering, manufacturing sciences, quality assurance, human resources, project management and business development.